BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Litigation Management Comments

BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn®September 13, 2018 7:30 AM